Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood

被引:44
作者
Ashton, James J. [1 ,2 ]
Borca, Florina [3 ]
Mossotto, Enrico [2 ,3 ]
Coelho, Tracy [1 ]
Batra, Akshay [1 ]
Afzal, Nadeem A. [1 ]
Phan, Hang T. T. [3 ]
Stanton, Michael [4 ]
Ennis, Sarah [2 ]
Beattie, Robert Mark [1 ,3 ]
机构
[1] Southampton Childrens Hosp, Dept Paediat Gastroenterol, Southampton, Hants, England
[2] Univ Southampton, Dept Human Genet & Genom Med, Southampton, Hants, England
[3] Univ Hosp Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England
[4] Southampton Childrens Hosp, Dept Paediat Surg, Southampton, Hants, England
关键词
NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; ULCERATIVE-COLITIS; RISING INCIDENCE; SURGERY; CHILDREN; INFLIXIMAB; MANAGEMENT; OUTCOMES; RISK;
D O I
10.1111/apt.15094
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Anti-tumour necrosis factor-alpha (anti-TNF) therapy use has risen in paediatric-onset inflammatory bowel disease (PIBD). Whether this has translated into preventing/delaying childhood surgery is uncertain. The Wessex PIBD cohort was analysed for trends in anti-TNF-therapy and surgery. Aim To assess patients diagnosed with PIBD within Wessex from 1997 to 2017. The prevalence of anti-TNF-therapy and yearly surgery rates (resection and perianal) during childhood (<18 years) were analysed (Pearson's correlation, multivariate regression, Fisher's exact). Results Eight-hundred-and-twenty-five children were included (498 Crohn's disease, 272 ulcerative colitis, 55 IBD-unclassified), mean age at diagnosis 13.6 years (1.6-17.6), 39.6% female. The prevalence of anti-TNF-treated patients increased from 5.1% to 27.1% (2007-2017), P = 0.0001. Surgical resection-rate fell (7.1%-1.5%, P = 0.001), driven by a decrease in Crohn's disease resections (8.9%-2.3%, P = 0.001). Perianal surgery and ulcerative colitis resection-rates were unchanged. Time from diagnosis to resection increased (1.6-2.8 years, P = 0.028) but mean age at resection was unchanged. Patients undergoing resections during childhood were diagnosed at a younger age in the most recent 5 years (2007-2011 = 13.1 years, 2013-2017 = 11.9 years, P = 0.014). Resection-rate in anti-TNF-therapy treated (16.1%) or untreated (12.2%) was no different (P = 0.25). Patients started on anti-TNF-therapy <3 years post-diagnosis (11.6%) vs later (28.6%) had a reduction in resections, P = 0.047. Anti-TNF-therapy prevalence was the only significant predictor of resection-rate using multivariate regression (P = 0.011). Conclusions The prevalence of anti-TNF-therapy increased significantly, alongside a decrease in surgical resection-rate. Patients diagnosed at younger ages still underwent surgery during childhood. Anti-TNF-therapy may reduce the need for surgical intervention in childhood, thereby influencing the natural history of PIBD.
引用
收藏
页码:398 / 407
页数:10
相关论文
共 53 条
[1]   Variation in Infliximab Administration Practices in the Treatment of Pediatric Inflammatory Bowel Disease [J].
Adler, Jeremy ;
Sandberg, Kelly C. ;
Shpeen, Benjamin H. ;
Eder, Sally J. ;
Dhanani, Muhammad ;
Clark, Sarah J. ;
Freed, Gary L. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 57 (01) :35-38
[2]   Infliximab delays but does not avoid the need for surgery in treatment-resistant pediatric crohn' disease [J].
Afzal, N. A. ;
Ozzard, A. ;
Keady, S. ;
Thomson, M. ;
Murch, S. ;
Heuschkel, R. .
DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (12) :3329-3333
[3]  
[Anonymous], 2013, J PEDIAT GASTROENTER
[4]   Presenting phenotype of paediatric inflammatory bowel disease in Wessex, Southern England 2010-2013 [J].
Ashton, J. J. ;
Coelho, T. ;
Ennis, S. ;
Batra, A. ;
Afzal, N. A. ;
Beattie, R. M. .
ACTA PAEDIATRICA, 2015, 104 (08) :831-837
[5]   Rising incidence of paediatric inflammatory bowel disease (PIBD) in Wessex, Southern England [J].
Ashton, J. J. ;
Wiskin, A. E. ;
Ennis, S. ;
Batra, A. ;
Afzal, N. A. ;
Beattie, R. M. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (07) :659-664
[6]   Endoscopic and Histological Assessment of Paediatric Inflammatory Bowel Disease Over a 3-Year Follow-up Period [J].
Ashton, James J. ;
Bonduelle, Quentin ;
Mossotto, Enrico ;
Coelho, Tracy ;
Batra, Akshay ;
Afzal, Nadeem A. ;
Vadgama, Bhumita ;
Ennis, Sarah ;
Beattie, R. Mark .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (03) :402-409
[7]   Improving remission rates in newly diagnosed paediatric ulcerative colitis [J].
Ashton, James J. ;
Beattie, R. Mark .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12) :838-839
[8]   Colectomy in pediatric ulcerative colitis: A single center experience of indications, outcomes, and complications [J].
Ashton, James J. ;
Versteegh, Hendt P. ;
Batra, Akshay ;
Afzal, Nadeem A. ;
King, Andrew ;
Griffiths, D. Mervyn ;
Beattie, R. Mark ;
Stanton, Michael P. .
JOURNAL OF PEDIATRIC SURGERY, 2016, 51 (02) :277-281
[9]   Paediatric inflammatory bowel disease: improving early diagnosis [J].
Ashton, James John ;
Harden, Anthony ;
Beattie, R. Mark .
ARCHIVES OF DISEASE IN CHILDHOOD, 2018, 103 (04) :307-308
[10]   Is the incidence of paediatric inflammatory bowel disease still increasing? [J].
Ashton, James John ;
Cullen, Mick ;
Afzal, Nadeem A. ;
Coelho, Tracy ;
Batra, Akshay ;
Beattie, R. Mark .
ARCHIVES OF DISEASE IN CHILDHOOD, 2018, 103 (11) :1093-+